View in EDS HTML Full Text PDF Full Text

Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.

Saved in:
Bibliographic Details
Title: Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.
Authors: Lin YT; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Division of Hematological Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan., Tsai XC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. xavierchtsai@ntu.edu.tw., Tien FM; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Kuo YY; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan., Tseng MH; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan., Liu JH; Department of Hematology and Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan., Ko BS; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.; Department of Hematology and Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan., Cheng CL; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chou SC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin ME; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin CC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chuang MK; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Yao M; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hou HA; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. hsinanhou@ntu.edu.tw.; Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. hsinanhou@ntu.edu.tw., Chou WC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei, Taiwan.
Source: Blood research [Blood Res] 2026 Jun 03; Vol. 61 (1). Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: Switzerland NLM ID: 101605247 Publication Model: Electronic Cited Medium: Print ISSN: 2287-979X (Print) Linking ISSN: 2287979X NLM ISO Abbreviation: Blood Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42230462
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lin+YT%22">Lin YT</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Division of Hematological Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Tsai+XC%22">Tsai XC</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. xavierchtsai@ntu.edu.tw.<br /><searchLink fieldCode="AU" term="%22Tien+FM%22">Tien FM</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kuo+YY%22">Kuo YY</searchLink>; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Tseng+MH%22">Tseng MH</searchLink>; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Liu+JH%22">Liu JH</searchLink>; Department of Hematology and Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ko+BS%22">Ko BS</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan.; Department of Hematology and Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheng+CL%22">Cheng CL</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chou+SC%22">Chou SC</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+ME%22">Lin ME</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CC%22">Lin CC</searchLink>; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chuang+MK%22">Chuang MK</searchLink>; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yao+M%22">Yao M</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hou+HA%22">Hou HA</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. hsinanhou@ntu.edu.tw.; Division of General Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. hsinanhou@ntu.edu.tw.<br /><searchLink fieldCode="AU" term="%22Chou+WC%22">Chou WC</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Tien+HF%22">Tien HF</searchLink>; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101605247%22">Blood research</searchLink> [Blood Res] 2026 Jun 03; Vol. 61 (1). <i>Date of Electronic Publication: </i>2026 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101605247 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2287-979X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222287979X%22">2287979X </searchLink><i>NLM ISO Abbreviation: </i>Blood Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42230462
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s44313-026-00144-3
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Real-world experience with gilteritinib maintenance following allogeneic transplantation in relapsed/refractory AML patients harboring FLT3 mutations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin YT
      – PersonEntity:
          Name:
            NameFull: Tsai XC
      – PersonEntity:
          Name:
            NameFull: Tien FM
      – PersonEntity:
          Name:
            NameFull: Kuo YY
      – PersonEntity:
          Name:
            NameFull: Tseng MH
      – PersonEntity:
          Name:
            NameFull: Liu JH
      – PersonEntity:
          Name:
            NameFull: Ko BS
      – PersonEntity:
          Name:
            NameFull: Cheng CL
      – PersonEntity:
          Name:
            NameFull: Chou SC
      – PersonEntity:
          Name:
            NameFull: Lin ME
      – PersonEntity:
          Name:
            NameFull: Lin CC
      – PersonEntity:
          Name:
            NameFull: Chuang MK
      – PersonEntity:
          Name:
            NameFull: Yao M
      – PersonEntity:
          Name:
            NameFull: Hou HA
      – PersonEntity:
          Name:
            NameFull: Chou WC
      – PersonEntity:
          Name:
            NameFull: Tien HF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 06
              Text: 2026 Jun 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2287-979X
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood research
              Type: main
ResultId 1